HAMAMATSU – The Hamamatsu University School of Medicine has partnered with the Sanford-Burnham Medical Research Institute to develop anti-cancer medicine with reduced side effects. The research group announced Tuesday that research and development are progressing and that experiments on animals have yielded positive results.
Cancerous mice were given 1/40 the usual dosage of anti-cancer medicine, and their tumors nearly disappeared by the 19th day of the test. Moreover, the researchers observed no side effects whatsoever.